Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Apr 18;282(6272):1278. doi: 10.1136/bmj.282.6272.1278

Impact of therapeutic audit on phenytoin prescribing.

I F Cawthorne, J H Silas
PMCID: PMC1505386  PMID: 6784817

Full text

PDF

Page 1278

1278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUCHTHAL F., SVENSMARK O., SCHILLER P. J. Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. Arch Neurol. 1960 Jun;2:624–630. doi: 10.1001/archneur.1960.03840120030004. [DOI] [PubMed] [Google Scholar]
  2. Bochner F., Hooper W. D., Tyrer J. H., Eadie M. J. Effect of dosage increments on blood phenytoin concentrations. J Neurol Neurosurg Psychiatry. 1972 Dec;35(6):873–876. doi: 10.1136/jnnp.35.6.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buchanan R. A., Kinkel A. W., Goulet J. R., Smith T. C. The metabolism of diphenylhydantoin (Dilantin) following once-daily administration. Neurology. 1972 Feb;22(2):126–130. doi: 10.1212/wnl.22.2.126. [DOI] [PubMed] [Google Scholar]
  4. Hopkins A., Scambler G. How doctors deal with epilepsy. Lancet. 1977 Jan 22;1(8004):183–186. doi: 10.1016/s0140-6736(77)91777-9. [DOI] [PubMed] [Google Scholar]
  5. Silas J. H., Cawthorne I. F. Hospital prescribing of phenytoin for epilepsy. J R Coll Physicians Lond. 1981 Jan;15(1):41–44. [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES